KöktürkUPüşüroğluHSomuncuMU, et al.Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2023;74:889-896.
2.
TymińskaAKapłon-CieślickaAOzierańskiK, et al.Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Pol Arch Intern Med. 2019;129:770-780.
3.
AslehREnriquez-SaranoMJaffeAS, et al.Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study. J Am Coll Cardiol. 2019;73:2286-2295.
4.
IsolaGPolizziAAlibrandiAWilliamsRCLo GiudiceA. Analysis of galectin-3 levels as a source of coronary heart disease risk during periodontitis. J Periodontal Res. 2021;56:597-605.
5.
TsigkouVSiasosGOikonomouE, et al.The prognostic role of galectin-3 and endothelial function in patients with heart failure. Cardiol J. 2022. doi:10.5603/CJ.a2022.0074
6.
RuanZBGaoRFWangF, et al.Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation. Cardiovasc Ther. 2022;2022:6993904.
7.
PranataRYonasEChintyaVTondasAERaharjoSB. Serum Galectin-3 level and recurrence of atrial fibrillation post-ablation - Systematic review and meta-analysis. Indian Pacing Electrophysiol J. 2020;20:64-69.
8.
KornejJSchmidlJUeberhamL, et al.Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation. PLoS One. 2015;10:e0123574.
